Kleiner Perkins Caufield & Byers, a venture capital firm in the Silicon Valley has just bet on adult stem cell research. While the amount of funding is still not known, we do know that they’ve invested in a new Bay Area company, iZumi Bio Inc.
Collaborative work with iZumi and San Francisco based J.David Gladstone Institutes, “will build on breakthrough methods of creating “induced pluripotent stem cells,” which are adult skin cells that can be coaxed to develop into many cell types. These cells might some day help to regenerate injured spinal cords or damaged hearts, scientists hope.
The technology sidesteps the ethical objections raised against research in human embryonic stem cells, which are derived from early stage human embryos that are often destroyed in the process. In addition, the technology may help avoid immune system rejection of replacement tissues, because an adult patient’s cell could be the source of stem cells that are a genetic match to that individual.
“We all feel the (induced pluripotent stem cells) technology has the potential to transform the regenerative medicine space,” said Thane Kreiner, chief executive officer of iZumi.””
Author Profile
- Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.
Latest entries
- FeaturedOctober 16, 2024Brava Italia! Jennifer Lahl, founder The Center for Bioethics and Culture
- FeaturedSeptember 9, 2024Don’t Make Claims Using Outdated Data
- BioethicsMay 16, 2024The Ethics of Transplantation Medicine
- infertilityApril 23, 2024The Rise of International Gestational Surrogacy in the U.S.